semaglutide
Sign in to savethumb|Semaglutide (Ozempic) Autoinjector|self-injection pen thumb|Prescription vial of semaglutide (Rybelsus) pills Semaglutide is an anti-diabetic medication used for the treatment of type2 diabetes, and an anti-obesity medication used for long-term weight management and to reduce the risk of major adverse cardiovascular events. It is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1), modified with a side chain. It can be administered by subcutaneous injection or taken orally. It is sold by Novo Nordisk under the brand names Ozempic and Rybelsus for diabetes, and under the bra
Key facts
- Drug.image
- Semaglutid 3Letter.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 350
- Drug.alt
- Structure of Semaglutide
- Drug.pronounce
- or
- Drug.tradename
- Ozempic, Rybelsus, Wegovy, others
- Drug.MedlinePlus
- a618008
- Drug.DailyMedID
- Semaglutide
- Drug.pregnancy_AU
- D
- Drug.routes_of_administration
- Subcutaneous, oral
- Drug.ATC_prefix
- A10
- Drug.ATC_suffix
- BJ06
- Drug.legal_AU
- S4
- Drug.legal_CA
- Rx-only
- Drug.legal_CA_comment
- /Schedule D
- Drug.legal_UK
- POM
- Drug.legal_US
- Rx-only
- Drug.legal_EU
- Rx-only
via Wikipedia infobox
Article
28 sectionsContents
- Medical uses
- United States
- European Union
- Side effects
- Contraindications
- Mechanism of action
- Structure and pharmacology
- History
- Clinical trials and early approvals for diabetes
- Trials for obesity
- Trials for cardiovascular health
- Society and culture
- Legal status
- Generics and copies
- India
- Brazil
- China
- Compounded versions
- Counterfeits
- Economics
- Cost, coverage and supply
- Economic impact on Denmark
- Rejection of Biden-Era Proposal
- Research
- Effect on lean body mass
- Notes
- References
- External links
thumb|Semaglutide (Ozempic) Autoinjector|self-injection pen thumb|Prescription vial of semaglutide (Rybelsus) pills
Semaglutide is an anti-diabetic medication used for the treatment of type2 diabetes, and an anti-obesity medication used for long-term weight management and to reduce the risk of major adverse cardiovascular events. It is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1), modified with a side chain. It can be administered by subcutaneous injection or taken orally. It is sold by Novo Nordisk under the brand names Ozempic and Rybelsus for diabetes, and under the brand name Wegovy for weight management, weight loss, and the treatment of metabolic-associated steatohepatitis (nonalcoholic steatohepatitis).